share_log

HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $18 Price Target

Moomoo 24/7 ·  Mar 5 07:04

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment